[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Covid-19 Impact on Global Antipyretic Drugs for Children Market Size, Status and Forecast 2020-2026

July 2020 | 92 pages | ID: C70DE1D129BFEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Antipyretic Drugs for Children are the drugs which are essentially help to reduce the elevated temperature to normal temperature i.e 37.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antipyretic Drugs for Children market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Antipyretic Drugs for Children industry.
Based on our recent survey, we have several different scenarios about the Antipyretic Drugs for Children YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Antipyretic Drugs for Children will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antipyretic Drugs for Children market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antipyretic Drugs for Children market in terms of revenue.
Players, stakeholders, and other participants in the global Antipyretic Drugs for Children market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.

Regional and Country-level Analysis

The report offers an exhaustive geographical analysis of the global Antipyretic Drugs for Children market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global Antipyretic Drugs for Children market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antipyretic Drugs for Children market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antipyretic Drugs for Children market.
The following players are covered in this report:
  • Mallinckrodt
  • Anqiu Lu'an
  • Granules India
  • Zhejiang Kangle
  • Farmson
  • Hebei Jiheng
  • Novacyl
  • Anhui BBCA Likang
  • Anhui Fubore
  • SKPL
  • Atabay
  • Huzhou Konch
Antipyretic Drugs for Children Breakdown Data by Type
  • Paracetamol
  • Aspirin
  • Ibuprofen
  • Noproxen
  • Diclofenac
  • Acetaminophen
Antipyretic Drugs for Children Breakdown Data by Application
  • Tablet Drug
  • Granules Drug
  • Oral Solution
  • Others
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antipyretic Drugs for Children Revenue
1.4 Market Analysis by Type
  1.4.1 Global Antipyretic Drugs for Children Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Paracetamol
  1.4.3 Aspirin
  1.4.4 Ibuprofen
  1.4.5 Noproxen
  1.4.6 Diclofenac
  1.4.7 Acetaminophen
1.5 Market by Application
  1.5.1 Global Antipyretic Drugs for Children Market Share by Application: 2020 VS 2026
  1.5.2 Tablet Drug
  1.5.3 Granules Drug
  1.5.4 Oral Solution
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Antipyretic Drugs for Children Industry Impact
  1.6.1 How the Covid-19 is Affecting the Antipyretic Drugs for Children Industry
    1.6.1.1 Antipyretic Drugs for Children Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Antipyretic Drugs for Children Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Antipyretic Drugs for Children Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Antipyretic Drugs for Children Market Perspective (2015-2026)
2.2 Antipyretic Drugs for Children Growth Trends by Regions
  2.2.1 Antipyretic Drugs for Children Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Antipyretic Drugs for Children Historic Market Share by Regions (2015-2020)
  2.2.3 Antipyretic Drugs for Children Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Antipyretic Drugs for Children Market Growth Strategy
  2.3.6 Primary Interviews with Key Antipyretic Drugs for Children Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Antipyretic Drugs for Children Players by Market Size
  3.1.1 Global Top Antipyretic Drugs for Children Players by Revenue (2015-2020)
  3.1.2 Global Antipyretic Drugs for Children Revenue Market Share by Players (2015-2020)
  3.1.3 Global Antipyretic Drugs for Children Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Antipyretic Drugs for Children Market Concentration Ratio
  3.2.1 Global Antipyretic Drugs for Children Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Antipyretic Drugs for Children Revenue in 2019
3.3 Antipyretic Drugs for Children Key Players Head office and Area Served
3.4 Key Players Antipyretic Drugs for Children Product Solution and Service
3.5 Date of Enter into Antipyretic Drugs for Children Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Antipyretic Drugs for Children Historic Market Size by Type (2015-2020)
4.2 Global Antipyretic Drugs for Children Forecasted Market Size by Type (2021-2026)

5 ANTIPYRETIC DRUGS FOR CHILDREN BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Antipyretic Drugs for Children Market Size by Application (2015-2020)
5.2 Global Antipyretic Drugs for Children Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Antipyretic Drugs for Children Market Size (2015-2020)
6.2 Antipyretic Drugs for Children Key Players in North America (2019-2020)
6.3 North America Antipyretic Drugs for Children Market Size by Type (2015-2020)
6.4 North America Antipyretic Drugs for Children Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Antipyretic Drugs for Children Market Size (2015-2020)
7.2 Antipyretic Drugs for Children Key Players in Europe (2019-2020)
7.3 Europe Antipyretic Drugs for Children Market Size by Type (2015-2020)
7.4 Europe Antipyretic Drugs for Children Market Size by Application (2015-2020)

8 CHINA

8.1 China Antipyretic Drugs for Children Market Size (2015-2020)
8.2 Antipyretic Drugs for Children Key Players in China (2019-2020)
8.3 China Antipyretic Drugs for Children Market Size by Type (2015-2020)
8.4 China Antipyretic Drugs for Children Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Antipyretic Drugs for Children Market Size (2015-2020)
9.2 Antipyretic Drugs for Children Key Players in Japan (2019-2020)
9.3 Japan Antipyretic Drugs for Children Market Size by Type (2015-2020)
9.4 Japan Antipyretic Drugs for Children Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Antipyretic Drugs for Children Market Size (2015-2020)
10.2 Antipyretic Drugs for Children Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Antipyretic Drugs for Children Market Size by Type (2015-2020)
10.4 Southeast Asia Antipyretic Drugs for Children Market Size by Application (2015-2020)

11 INDIA

11.1 India Antipyretic Drugs for Children Market Size (2015-2020)
11.2 Antipyretic Drugs for Children Key Players in India (2019-2020)
11.3 India Antipyretic Drugs for Children Market Size by Type (2015-2020)
11.4 India Antipyretic Drugs for Children Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Antipyretic Drugs for Children Market Size (2015-2020)
12.2 Antipyretic Drugs for Children Key Players in Central & South America (2019-2020)
12.3 Central & South America Antipyretic Drugs for Children Market Size by Type (2015-2020)
12.4 Central & South America Antipyretic Drugs for Children Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Mallinckrodt
  13.1.1 Mallinckrodt Company Details
  13.1.2 Mallinckrodt Business Overview and Its Total Revenue
  13.1.3 Mallinckrodt Antipyretic Drugs for Children Introduction
  13.1.4 Mallinckrodt Revenue in Antipyretic Drugs for Children Business (2015-2020))
  13.1.5 Mallinckrodt Recent Development
13.2 Anqiu Lu'an
  13.2.1 Anqiu Lu'an Company Details
  13.2.2 Anqiu Lu'an Business Overview and Its Total Revenue
  13.2.3 Anqiu Lu'an Antipyretic Drugs for Children Introduction
  13.2.4 Anqiu Lu'an Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.2.5 Anqiu Lu'an Recent Development
13.3 Granules India
  13.3.1 Granules India Company Details
  13.3.2 Granules India Business Overview and Its Total Revenue
  13.3.3 Granules India Antipyretic Drugs for Children Introduction
  13.3.4 Granules India Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.3.5 Granules India Recent Development
13.4 Zhejiang Kangle
  13.4.1 Zhejiang Kangle Company Details
  13.4.2 Zhejiang Kangle Business Overview and Its Total Revenue
  13.4.3 Zhejiang Kangle Antipyretic Drugs for Children Introduction
  13.4.4 Zhejiang Kangle Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.4.5 Zhejiang Kangle Recent Development
13.5 Farmson
  13.5.1 Farmson Company Details
  13.5.2 Farmson Business Overview and Its Total Revenue
  13.5.3 Farmson Antipyretic Drugs for Children Introduction
  13.5.4 Farmson Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.5.5 Farmson Recent Development
13.6 Hebei Jiheng
  13.6.1 Hebei Jiheng Company Details
  13.6.2 Hebei Jiheng Business Overview and Its Total Revenue
  13.6.3 Hebei Jiheng Antipyretic Drugs for Children Introduction
  13.6.4 Hebei Jiheng Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.6.5 Hebei Jiheng Recent Development
13.7 Novacyl
  13.7.1 Novacyl Company Details
  13.7.2 Novacyl Business Overview and Its Total Revenue
  13.7.3 Novacyl Antipyretic Drugs for Children Introduction
  13.7.4 Novacyl Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.7.5 Novacyl Recent Development
13.8 Anhui BBCA Likang
  13.8.1 Anhui BBCA Likang Company Details
  13.8.2 Anhui BBCA Likang Business Overview and Its Total Revenue
  13.8.3 Anhui BBCA Likang Antipyretic Drugs for Children Introduction
  13.8.4 Anhui BBCA Likang Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.8.5 Anhui BBCA Likang Recent Development
13.9 Anhui Fubore
  13.9.1 Anhui Fubore Company Details
  13.9.2 Anhui Fubore Business Overview and Its Total Revenue
  13.9.3 Anhui Fubore Antipyretic Drugs for Children Introduction
  13.9.4 Anhui Fubore Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.9.5 Anhui Fubore Recent Development
13.10 SKPL
  13.10.1 SKPL Company Details
  13.10.2 SKPL Business Overview and Its Total Revenue
  13.10.3 SKPL Antipyretic Drugs for Children Introduction
  13.10.4 SKPL Revenue in Antipyretic Drugs for Children Business (2015-2020)
  13.10.5 SKPL Recent Development
13.11 Atabay
  10.11.1 Atabay Company Details
  10.11.2 Atabay Business Overview and Its Total Revenue
  10.11.3 Atabay Antipyretic Drugs for Children Introduction
  10.11.4 Atabay Revenue in Antipyretic Drugs for Children Business (2015-2020)
  10.11.5 Atabay Recent Development
13.12 Huzhou Konch
  10.12.1 Huzhou Konch Company Details
  10.12.2 Huzhou Konch Business Overview and Its Total Revenue
  10.12.3 Huzhou Konch Antipyretic Drugs for Children Introduction
  10.12.4 Huzhou Konch Revenue in Antipyretic Drugs for Children Business (2015-2020)
  10.12.5 Huzhou Konch Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. Antipyretic Drugs for Children Key Market Segments
Table 2. Key Players Covered: Ranking by Antipyretic Drugs for Children Revenue
Table 3. Ranking of Global Top Antipyretic Drugs for Children Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Antipyretic Drugs for Children Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Paracetamol
Table 6. Key Players of Aspirin
Table 7. Key Players of Ibuprofen
Table 8. Key Players of Noproxen
Table 9. Key Players of Diclofenac
Table 10. Key Players of Acetaminophen
Table 11. COVID-19 Impact Global Market: (Four Antipyretic Drugs for Children Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Antipyretic Drugs for Children Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Antipyretic Drugs for Children Players to Combat Covid-19 Impact
Table 16. Global Antipyretic Drugs for Children Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Antipyretic Drugs for Children Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Antipyretic Drugs for Children Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Antipyretic Drugs for Children Market Share by Regions (2015-2020)
Table 20. Global Antipyretic Drugs for Children Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Antipyretic Drugs for Children Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Antipyretic Drugs for Children Market Growth Strategy
Table 26. Main Points Interviewed from Key Antipyretic Drugs for Children Players
Table 27. Global Antipyretic Drugs for Children Revenue by Players (2015-2020) (Million US$)
Table 28. Global Antipyretic Drugs for Children Market Share by Players (2015-2020)
Table 29. Global Top Antipyretic Drugs for Children Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antipyretic Drugs for Children as of 2019)
Table 30. Global Antipyretic Drugs for Children by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Antipyretic Drugs for Children Product Solution and Service
Table 33. Date of Enter into Antipyretic Drugs for Children Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 36. Global Antipyretic Drugs for Children Market Size Share by Type (2015-2020)
Table 37. Global Antipyretic Drugs for Children Revenue Market Share by Type (2021-2026)
Table 38. Global Antipyretic Drugs for Children Market Size Share by Application (2015-2020)
Table 39. Global Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 40. Global Antipyretic Drugs for Children Market Size Share by Application (2021-2026)
Table 41. North America Key Players Antipyretic Drugs for Children Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Antipyretic Drugs for Children Market Share (2019-2020)
Table 43. North America Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 44. North America Antipyretic Drugs for Children Market Share by Type (2015-2020)
Table 45. North America Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 46. North America Antipyretic Drugs for Children Market Share by Application (2015-2020)
Table 47. Europe Key Players Antipyretic Drugs for Children Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Antipyretic Drugs for Children Market Share (2019-2020)
Table 49. Europe Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Antipyretic Drugs for Children Market Share by Type (2015-2020)
Table 51. Europe Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Antipyretic Drugs for Children Market Share by Application (2015-2020)
Table 53. China Key Players Antipyretic Drugs for Children Revenue (2019-2020) (Million US$)
Table 54. China Key Players Antipyretic Drugs for Children Market Share (2019-2020)
Table 55. China Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 56. China Antipyretic Drugs for Children Market Share by Type (2015-2020)
Table 57. China Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 58. China Antipyretic Drugs for Children Market Share by Application (2015-2020)
Table 59. Japan Key Players Antipyretic Drugs for Children Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Antipyretic Drugs for Children Market Share (2019-2020)
Table 61. Japan Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Antipyretic Drugs for Children Market Share by Type (2015-2020)
Table 63. Japan Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Antipyretic Drugs for Children Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Antipyretic Drugs for Children Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Antipyretic Drugs for Children Market Share (2019-2020)
Table 67. Southeast Asia Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Antipyretic Drugs for Children Market Share by Type (2015-2020)
Table 69. Southeast Asia Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Antipyretic Drugs for Children Market Share by Application (2015-2020)
Table 71. India Key Players Antipyretic Drugs for Children Revenue (2019-2020) (Million US$)
Table 72. India Key Players Antipyretic Drugs for Children Market Share (2019-2020)
Table 73. India Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 74. India Antipyretic Drugs for Children Market Share by Type (2015-2020)
Table 75. India Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 76. India Antipyretic Drugs for Children Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Antipyretic Drugs for Children Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Antipyretic Drugs for Children Market Share (2019-2020)
Table 79. Central & South America Antipyretic Drugs for Children Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Antipyretic Drugs for Children Market Share by Type (2015-2020)
Table 81. Central & South America Antipyretic Drugs for Children Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Antipyretic Drugs for Children Market Share by Application (2015-2020)
Table 83. Mallinckrodt Company Details
Table 84. Mallinckrodt Business Overview
Table 85. Mallinckrodt Product
Table 86. Mallinckrodt Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 87. Mallinckrodt Recent Development
Table 88. Anqiu Lu'an Company Details
Table 89. Anqiu Lu'an Business Overview
Table 90. Anqiu Lu'an Product
Table 91. Anqiu Lu'an Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 92. Anqiu Lu'an Recent Development
Table 93. Granules India Company Details
Table 94. Granules India Business Overview
Table 95. Granules India Product
Table 96. Granules India Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 97. Granules India Recent Development
Table 98. Zhejiang Kangle Company Details
Table 99. Zhejiang Kangle Business Overview
Table 100. Zhejiang Kangle Product
Table 101. Zhejiang Kangle Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 102. Zhejiang Kangle Recent Development
Table 103. Farmson Company Details
Table 104. Farmson Business Overview
Table 105. Farmson Product
Table 106. Farmson Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 107. Farmson Recent Development
Table 108. Hebei Jiheng Company Details
Table 109. Hebei Jiheng Business Overview
Table 110. Hebei Jiheng Product
Table 111. Hebei Jiheng Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 112. Hebei Jiheng Recent Development
Table 113. Novacyl Company Details
Table 114. Novacyl Business Overview
Table 115. Novacyl Product
Table 116. Novacyl Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 117. Novacyl Recent Development
Table 118. Anhui BBCA Likang Business Overview
Table 119. Anhui BBCA Likang Product
Table 120. Anhui BBCA Likang Company Details
Table 121. Anhui BBCA Likang Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 122. Anhui BBCA Likang Recent Development
Table 123. Anhui Fubore Company Details
Table 124. Anhui Fubore Business Overview
Table 125. Anhui Fubore Product
Table 126. Anhui Fubore Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 127. Anhui Fubore Recent Development
Table 128. SKPL Company Details
Table 129. SKPL Business Overview
Table 130. SKPL Product
Table 131. SKPL Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 132. SKPL Recent Development
Table 133. Atabay Company Details
Table 134. Atabay Business Overview
Table 135. Atabay Product
Table 136. Atabay Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 137. Atabay Recent Development
Table 138. Huzhou Konch Company Details
Table 139. Huzhou Konch Business Overview
Table 140. Huzhou Konch Product
Table 141. Huzhou Konch Revenue in Antipyretic Drugs for Children Business (2015-2020) (Million US$)
Table 142. Huzhou Konch Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Antipyretic Drugs for Children Market Share by Type: 2020 VS 2026
Figure 2. Paracetamol Features
Figure 3. Aspirin Features
Figure 4. Ibuprofen Features
Figure 5. Noproxen Features
Figure 6. Diclofenac Features
Figure 7. Acetaminophen Features
Figure 8. Global Antipyretic Drugs for Children Market Share by Application: 2020 VS 2026
Figure 9. Tablet Drug Case Studies
Figure 10. Granules Drug Case Studies
Figure 11. Oral Solution Case Studies
Figure 12. Others Case Studies
Figure 13. Antipyretic Drugs for Children Report Years Considered
Figure 14. Global Antipyretic Drugs for Children Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Antipyretic Drugs for Children Market Share by Regions: 2020 VS 2026
Figure 16. Global Antipyretic Drugs for Children Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Antipyretic Drugs for Children Market Share by Players in 2019
Figure 19. Global Top Antipyretic Drugs for Children Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antipyretic Drugs for Children as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Antipyretic Drugs for Children Revenue in 2019
Figure 21. North America Antipyretic Drugs for Children Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Antipyretic Drugs for Children Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Antipyretic Drugs for Children Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Antipyretic Drugs for Children Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Antipyretic Drugs for Children Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Antipyretic Drugs for Children Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Antipyretic Drugs for Children Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Mallinckrodt Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 30. Anqiu Lu'an Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Anqiu Lu'an Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 32. Granules India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Granules India Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 34. Zhejiang Kangle Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Zhejiang Kangle Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 36. Farmson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Farmson Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 38. Hebei Jiheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Hebei Jiheng Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 40. Novacyl Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Novacyl Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 42. Anhui BBCA Likang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Anhui BBCA Likang Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 44. Anhui Fubore Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Anhui Fubore Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 46. SKPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. SKPL Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 48. Atabay Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Atabay Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 50. Huzhou Konch Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Huzhou Konch Revenue Growth Rate in Antipyretic Drugs for Children Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed


More Publications